RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Genextra
G

Genextra portfolio

Genextra has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $78.63M.
Latest deal: InnovHeart · Jan 27, 2022.
About this page

Its most recent investment on record is InnovHeart's $55M Series B+ round in January 2022, alongside Panakes Partners, China Grand Pharmaceutical and Healthcare Holdings and Indaco Venture Partners. That company is in Health and bio. It has co-invested with Panakes Partners, Indaco Venture Partners and China Grand Pharmaceutical and Healthcare Holdings, most often Panakes Partners (2 rounds).

What Genextra invests in

How Genextra invests

StageDealsCapital in rounds
Series B+ 2 100%$78.63M
YearDealsCapital in rounds
2020 1 50%$23.63M
2022 1 50%$55M

Genextra portfolio companies

CompanyRound with GenextraTotal raisedLatest raise
IInnovHeart
Health and bio
 Series B+ · $55M$78.63MJan 27, 2022
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Genextra. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Genextra, which is a subset of its real portfolio. API: /api/v1/investors/genextra (get a free API key). More: the most active VC firms and new venture capital funds.